参考文献：
[1] Mesenchymal stem cells in health and disease | Nature Reviews Immunology[EB/OL]. [2024-07-15]. https://www.nature.com/articles/nri2395.
链接：https://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-12-8
[2] Ankrum J A, Ong J F, Karp J M. Mesenchymal stem cells: immune evasive, not immune privileged[J]. Nature Biotechnology, 2014, 32(3): 252-260.
链接：https://pubmed.ncbi.nlm.nih.gov/24561556/
[3] Bagno L L, Salerno A G, Balkan W, et al. Mechanism of Action of Mesenchymal Stem Cells (MSCs): impact of delivery method[J]. Expert Opinion on Biological Therapy, 2022[2024-07-18].
链接：https://www.tandfonline.com/doi/abs/10.1080/14712598.2022.2016695
[4] Ikebe C, Suzuki K. Mesenchymal Stem Cells for Regenerative Therapy: Optimization of Cell Preparation Protocols[J]. BioMed Research International, 2014, 2014(1): 951512.
链接：https://onlinelibrary.wiley.com/doi/full/10.1155/2014/951512
[5] Fernández-Santos M E, Garcia-Arranz M, Andreu E J, et al. Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome[J]. Frontiers in Immunology, 2022, 13.
链接：https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.918565/full
[6] Carp D M, Liang Y. Universal or Personalized Mesenchymal Stem Cell Therapies: Impact of Age, Sex, and Biological Source[J]. Cells, 2022, 11(13): 2077.
链接：https://www.mdpi.com/2073-4409/11/13/2077#B42-cells-11-02077
[7] Stolzing A, Jones E, McGonagle D, et al. Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies[J]. Mechanisms of Ageing and Development, 2008, 129(3): 163-173.
链接：https://www.sciencedirect.com/science/article/pii/S0047637407001790?via=ihub
[8] Zanotti S, Kalajzic I, Aguila H L, et al. Sex and Genetic Factors Determine Osteoblastic Differentiation Potential of Murine Bone Marrow Stromal Cells[J]. PLoS ONE, 2014, 9(1): e86757.
链接：https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904935/
[9] Saeedi P, Halabian R, Imani Fooladi AA. A revealing review of mesenchymal stem cells therapy, clinical perspectives and Modification strategies. Stem Cell Investig. 2019 Sep 25;6:34. doi: 10.21037/sci.2019.08.11. PMID: 31620481; PMCID: PMC6789202.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789202/
[10] Macrin, D., Joseph, J.P., Pillai, A.A. et al. Eminent Sources of Adult Mesenchymal Stem Cells and Their Therapeutic Imminence. Stem Cell Rev and Rep 13, 741–756 (2017).
